HOTH
Hoth Therapeutics, Inc.
Key Financials
Operating Income
$-12361349
↓ 50.5%
Net Income
$-12469302
↓ 52.3%
EPS (Diluted)
$-0.90
↑ 29.7%
Total Liabilities
$1.5M
↑ 74.2%
Cash & Equivalents
$6.2M
↓ 11.2%
Total Assets
$7.6M
↓ 1.4%
Shareholders' Equity
$6.2M
↓ 10.6%
Revenue
$1.2B
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HOTH |
| Company Name | Hoth Therapeutics, Inc. |
| CIK | 1711786 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (646)756-2997 |